We have tested three different techniques including pyrosequencing, LD (ligation-dependent)-PCR and NGS in a series of peripheral blood specimens from chronic myeloid leukemia (CML) patients carrying single or multiple mutations in the BCR-ABL1 KD. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.